Syridex Bio

About Syridex Bio

Syridex Bio is an impact-driven, life sciences-focused firm dedicated to investing in therapies that address the needs of underserved communities, with a mission to accelerate health equity.

Products & Services

Investment in Therapies:Investing in life sciences therapies targeting underserved communities.

Specialties

Health Equity Therapies for Underserved Communities Impact-Driven Investments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Government Allocation T: - FT: Government Allocation	A: 5000000 MR: - FA: up to $5 million FAN: 5000000	D: 2023-05-23 FD: 2023-05-23	1 investors

Government Allocation Latest

2023-05-23

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Squire Servance

Managing Partner

J

Joshua Adeoye, MD

Physician-Scientist

V

Veleka Peeples-Dyer

Partner

C

Christopher Whitfield

Advisory Partner

C

Charles Corpening

Private Equity Investor

B

Ben Duster

Founder and CEO

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Syridex Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised